N-Nitro-1,2,3,4-tetradehydro Argatroban Ethyl Ester CAS 74874-09-2 Purity ≥99.0% Argatroban Intermediate

Short Description:

Name: N-Nitro-1,2,3,4-tetradehydro Argatroban Ethyl Ester

Synonyms: Argatroban Intermediate-5

CAS: 74874-09-2

Appearance: White or Off-White Crystalline Powder

Purity: ≥99.0%

Intermediate of Argatroban, a Synthetic Antithrombotic Agent 

E-mail: alvin@ruifuchem.com


Product Detail

Related Products

Product Tags

Description:

Chemical Properties:

Chemical Name N-Nitro-1,2,3,4-tetradehydro Argatroban Ethyl Ester
Synonyms Argatroban Intermediate-5 
CAS Number 74874-09-2
CAT Number RF-PI268
Stock Status In Stock, Production Scale Up to Hundreds of Kilograms
Molecular Formula C25H35N7O7S
Molecular Weight 577.65
Shipping Condition Shipped Under Ambient Temperature
Brand Ruifu Chemical

Specifications:

Item Specifications
Appearance White or Off-White Crystalline Powder
Purity ≥99.0%
Related Substance ≤2.0%
Enantiomorph ≤0.30%
Residual Solvents
Methanol ≤0.30%
Ethanol ≤0.50%
Dichloromethane ≤0.03%
Acetic Ether ≤0.50%
Triethylamine ≤0.03%
Toluene ≤0.10%
Heavy Metals ≤20ppm
Loss on Drying ≤0.50%
Residue on Ignition ≤0.20%
Test Standard Enterprise Standard
Usage Argatroban Intermediate-5

Package & Storage:

Package: Bottle, Aluminium foil bag, Cardboard Drum, 25kg/Drum, or according to customer's requirement.

Storage Condition: Store in sealed containers at cool and dry place; Protect from light, moisture and pest infestation.

Advantages:

1

FAQ:

Application:

Shanghai Ruifu Chemical Co., Ltd. is the leading manufacturer and supplier of Argatroban Intermediate-5, N-Nitro-1,2,3,4-tetradehydro Argatroban Ethyl Ester (CAS: 74874-09-2) with high quality, is an intermediate of Argatroban Monohydrate (CAS 141396-28-3) or Argatroban Anhydrous (CAS 74863-84-6).

Argatroban is a new synthetic antithrombotic agent useful in maintenance anticoagulation them ischemic stroke and disseminated intravascular coagulation. Argatroban is an anticoagulant that acts as a potent, seletive, univalent direct inhibitor of thrombin. Argatroban was approved in 2000 for prophylaxis or treatment of thrombosis in patients with heparin-induced thrombocytopenia (HIT).

  • Write your message here and send it to us